RECRUITING

Increasing CGM Use Among Patients With T2D

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Study Overview: This interventional study aims to assess whether training healthcare professionals (HCPs) increases the number of continuous glucose monitor (CGM) prescriptions for patients with Type 2 Diabetes in a Federally Qualified Health Center serving a predominantly Hispanic/Latino population. Research Questions: Does HCP training enhance CGM prescription rates in a primary care setting? Does receiving a CGM prescription lead to improved Type 2 Diabetes control, as measured by Hemoglobin A1c levels? What barriers do patients face when prescribed and using CGMs? Given the significant impact of CGMs on diabetes management, this project seeks to improve CGM utilization among eligible patients through a focused intervention for HCPs and evaluate diabetes outcomes for those who do and do not receive a CGM. Methodology: HCPs and staff from three clinics within the same healthcare system will undergo a brief, in-person training on current clinical guidelines and insurance eligibility for CGMs. A booster session will follow about one month later to reinforce learning and address any prescribing challenges. Training efficacy will be evaluated by comparing CGM prescription rates before and after training using electronic health records. HCPs will complete pre- and post-training surveys to assess changes in knowledge, beliefs, and prescribing practices related to CGMs. Additionally, a small subset of prescribers will participate in interviews about their experiences with CGM prescriptions four months post-training. Patient Recruitment and Surveys: Patients with Type 2 Diabetes will be recruited for surveys at baseline, and at 3 and 6 months. These surveys will gather information on their diabetes management experience, levels of diabetes distress, and whether CGM discussions occurred with their primary care provider. Participants who received CGM prescriptions will share their experiences and any barriers encountered. A subset will also be invited for interviews to further explore their CGM experiences. Conclusion: This study seeks to fill a crucial gap in understanding how HCP training influences CGM prescription rates and the associated diabetes management outcomes, ultimately aiming to enhance diabetes care for a vulnerable population.

Official Title

Increasing Use of Continuous Glucose Monitors Among Patients With Type 2 Diabetes

Quick Facts

Study Start:2024-10-25
Study Completion:2027-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06638099

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Julie L Pickrel, MPH
CONTACT
1+ 619-594-3369
jpickrel@sdsu.edu
Nicole Rivera
CONTACT
1+ (760)-768-5549
Nrivera3@sdsu.edu

Principal Investigator

Emily Schmied,, PhD
PRINCIPAL_INVESTIGATOR
San Diego State University
Shiloh Williams, PhD RN
PRINCIPAL_INVESTIGATOR
San Diego State University

Study Locations (Sites)

Innercare Inc
El Centro, California, 92243
United States
Innercare, Inc
El Centro, California, 92243
United States

Collaborators and Investigators

Sponsor: San Diego State University

  • Emily Schmied,, PhD, PRINCIPAL_INVESTIGATOR, San Diego State University
  • Shiloh Williams, PhD RN, PRINCIPAL_INVESTIGATOR, San Diego State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-25
Study Completion Date2027-09-30

Study Record Updates

Study Start Date2024-10-25
Study Completion Date2027-09-30

Terms related to this study

Keywords Provided by Researchers

  • Diabetes Mellitus Type 2
  • Continuous Glucose Monitor
  • FQHC Intervention
  • health care providers
  • CGM Education

Additional Relevant MeSH Terms

  • Diabetes
  • Diabetes Mellitus
  • Diabetes Mellitus Type 2
  • Diabetes Mellitus Type 2 (T2DM)